Clinical Trials Logo

Obstructive Jaundice clinical trials

View clinical trials related to Obstructive Jaundice.

Filter by:

NCT ID: NCT03406676 Recruiting - Clinical trials for Obstructive Jaundice

Pre-treatment With Methylene Blue Prevent Peri-operative Reduced Systemic Vascular Resistance

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

To explore the effects of pre-treatment with methylene blue on reduced perioperative vascular resistance in patients with obstructive jaundice.

NCT ID: NCT03376945 Completed - Clinical trials for Surgical Procedure, Unspecified

Application of n-3 Fatty to Patient of Jaundice

Start date: January 1, 2014
Phase: N/A
Study type: Observational

The safety and efficacy of ω-3 fatty acid in patients with obstructive jaundice is not known. This study provided evidences that ω-3 fatty acid-based parenteral nutrition improved postoperative recovery for patients with obstructive jaundice.

NCT ID: NCT03133026 Recruiting - Cholangitis Clinical Trials

Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation

Start date: June 2016
Phase: N/A
Study type: Interventional

Primary Objective: To document state-of- the-art multi-modality management of occluded biliary SEMS aiming to minimize number of reinterventions while providing symptom relief without procedure-related serious adverse events. NOTE: This study will be hypothesis-generating for an anticipated randomized controlled study (RCT) to compare outcomes of placement of a plastic stent inside the occluded SEMS to outcomes of the proposed multi-modality approach.

NCT ID: NCT02797665 Recruiting - Clinical trials for Obstructive Jaundice

Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids

Start date: May 2016
Phase: N/A
Study type: Interventional

This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.

NCT ID: NCT02468076 Completed - Cholangiocarcinoma Clinical Trials

Radiofrequency Ablation for Biliopancreatic Malignancy

IGNITE-1
Start date: November 2014
Phase: Phase 2
Study type: Interventional

This phase-2 study aims to evaluate feasibility, safety and efficacy of thermal ablation of biliary obstructive malignancies by means of radiofrequency ablation (RFA, ELRA, StarMed) during endoscopic retrograde cholangio-pancreaticography (ERCP) with primary intent to obtain palliative biliary drainage via stenting

NCT ID: NCT02166840 Completed - Clinical trials for Obstructive Jaundice

Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.

SEMS
Start date: March 2007
Phase: Phase 2
Study type: Interventional

Patients with obstructive jaundice due to periampullary tumor can temporarily be relieved of their jaundice with transpapillary stenting at endoscopic retrograde cholangio-pancreatography (ERCP) prior to operation. Usually plastic stents are used. Hypothesis: Self expanding metallic stents offer a be a better alternative for preoperative stenting in patients with obstructive jaundice due to periampullary tumour obstruction.

NCT ID: NCT01688375 Not yet recruiting - Clinical trials for Obstructive Jaundice

The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice

Start date: December 2012
Phase: Phase 2
Study type: Interventional

ABSTRACT: In patients with obstructive jaundice, multi-organ dysfunction may develop. The aim of this study is to evaluate the effect of ursodeoxycholic acid on liver functional restoration on patients with obstructive jaundice after surgical or endoscopic treatment. Patients with obstructive jaundice will be divided into two groups: (A) test group in which will be administered ursodeoxycholic acid twenty-four hours after endoscopic or surgical procedure and will last fourteen days, and (B) control group. Serum-testing will include determination of bilirubin, alanine transaminase, aspartate transaminase, gama-glutamyl transpeptidase, alkaline phosphatase, albumin, and cholesterol levels. These parameters will be determined one day prior endoscopic or surgical procedure, and on the third, fifth, seventh, tenth, twelfth and fourteenth days after endoscopic or surgical intervention. Our hypothesis is that patients with obstructive jaundice under treatment with ursodeoxycholic acid will have better outcome than patients in control group.

NCT ID: NCT01675908 Completed - Pancreatic Cancer Clinical Trials

Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression

Start date: August 22, 2012
Phase: N/A
Study type: Interventional

Compare the performance of full covered metal stents and plastic stents for preoperative biliary decompression

NCT ID: NCT01622803 Withdrawn - Clinical trials for Obstructive Jaundice

Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction

Start date: August 2011
Phase: Phase 3
Study type: Interventional

Internal biliary drainage using stent is used for malignant hilar obstruction such as cholangiocarcinoma, hepatocellular carcinoma and other malignancy including metastasis. Bilateral drainage is more physiologic and have more long patency than unilateral drainage. There are two methods of bilateral drainage: Y-stent and side by side. However there are no clinical data about comparing the effectiveness of these two methods. Therefore the investigators want to compare the clinical outcomes of two methods: Y-stent and side by side.

NCT ID: NCT01506115 Completed - Clinical trials for Hepatocellular Carcinoma

Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

Start date: September 2009
Phase: N/A
Study type: Interventional

The prognosis of patients with obstructive jaundice caused by hepatocellular carcinoma (HCC) is dismal even after biliary drainage; due to malfunction of the biliary drainage tube caused by hemobilia and/or tumor emboli. Photodynamic therapy (PDT) in hilar cholangiocarcinoma improves biliary drainage and prolongs survival. The aims of this study were to assess the safety and efficacy of PDT in unresectable HCC with bile duct invasion.